Health Technology Assessment (HTA)
4 European H2020 organizations list this as part of their work — 4 as their primary capability.
Most active in this area
- NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE
UK's national authority on health technology assessment, contributing HTA, health economics, and data standards expertise to European health research consortia.
“Central to ADAPT-SMART, IMPACT HTA, HTx, GetReal Initiative, and NEURONET — all focused on improving how health technologies are evaluated for adoption.”
PrimaryUK13 projects - SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG
Hungarian health economics SME specializing in HTA, cost-effectiveness modelling, and real-world evidence for EU health policy decisions.
“Core contributor to HTx (next-generation HTA), COMED (cost and outcome analysis of medical technologies), and HEcoPerMed (pharma-economic models for personalised medicine).”
PrimarySMEHU7 projects - TANDVARDS-OCH LAKEMEDELSFORMANSVERKET
Sweden's pharmaceutical reimbursement authority, contributing regulatory HTA expertise and real-world pricing decision experience to European health research consortia.
“All three projects (DO-IT, IMPACT HTA, HTx) center on improving HTA methods, from outcome measurement to next-generation assessment frameworks.”
PrimarySE3 projects - ZORGINSTITUUT NEDERLAND
Dutch national HTA authority contributing reimbursement expertise and real-world evidence methods to European health research consortia.
“Central theme across all three projects: ADAPT-SMART (HTA and reimbursement pathways), GetReal Initiative, and HTx (next-generation HTA methods).”
PrimaryNL3 projects